Skip to main content

Publisher: Wiley-Blackwell

Volume 128, Number 2, 1 August 2013

Switching from natalizumab to fingolimod: an observational study
pp. e6-e10(5)
Authors: Sempere, A. P.; Martín‐Medina, P.; Berenguer‐Ruiz, L.; Pérez‐Carmona, N.; Sanchez‐Perez, R.; Polache‐Vengud, J.; Feliu‐Rey, E.

Favourites:
ADD

Elevated homocysteine levels in levodopa‐treated idiopathic Parkinson's disease: a meta‐analysis
pp. 73-82(10)
Authors: Hu, X.‐W.; Qin, S.‐M.; Li, D.; Hu, L.‐F.; Liu, C.‐F.

Favourites:
ADD

Epilepsy treatment gap: prevalence and associated factors in Southeast Nigeria
pp. 83-90(8)
Authors: Nwani, P. O.; Nwosu, M. C.; Enwereji, K. O.; Asomugha, A. L.; Arinzechi, E. O.; Ogunniyi, A. O.

Favourites:
ADD

Indirect comparison of clobazam and other therapies for Lennox–Gastaut syndrome
pp. 91-99(9)
Authors: Cramer, J. A.; Sapin, C.; François, C.

Favourites:
ADD

High‐frequency rTMS using a double cone coil for gait disturbance
pp. 100-106(7)
Authors: Kakuda, W.; Abo, M.; Nakayama, Y.; Kiyama, A.; Yoshida, H.

Favourites:
ADD

Treatment in early Parkinson's disease: the Norwegian ParkWest study
pp. 107-113(7)
Authors: Tveiten, O. V.; Skeie, G. O.; Haugarvoll, K.; Müller, B.; Larsen, J. P.; Tysnes, O. B.

Favourites:
ADD

Comparison of patient‐reported outcome measures in multiple sclerosis
pp. 114-121(8)
Authors: Schäffler, N.; Schönberg, P.; Stephan, J.; Stellmann, J.‐P.; Gold, S. M.; Heesen, C.

Favourites:
ADD

MoCA and MMSE are both valid cognitive tools in stroke
pp. 122-129(8)
Authors: Cumming, T. B.; Churilov, L.; Linden, T.; Bernhardt, J.

Favourites:
ADD
Favourites:
ADD

MCCC1/LAMP3 reduces risk of sporadic Parkinson's disease in Han Chinese
pp. 136-139(4)
Authors: Li, N. N.; Tan, E. K.; Chang, X. L.; Mao, X. Y.; Zhao, D. M.; Zhang, J. H.; Liao, Q.; Peng, R.

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more